PEOPLE - Changes at EPIX Medical:
This article was originally published in Clinica
Dr Stephen Knight, vice-president of finance and business development at EPIX Medical, has assumed the additional role of chief financial officer. He succeeds Jeffrey Lentz who leaves the US developer of MRI contrast agents to join i-Logix, a software developer.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.